Cargando…
Usability of daily SF36 questionnaires to capture the QALD variation experienced after vaccination with AS03(A)-adjuvanted monovalent influenza A (H5N1) vaccine in a safety and tolerability study
BACKGROUND: This study aims to describe the short-term reactogenicity of the AS03-adjuvanted H5N1 vaccine expressed through adverse events (AEs) and quality-adjusted life-day (QALD) scores. The AEs are likely to be short-term and therefore the quality of life (QoL) questionnaire, SF-36v2, was admini...
Autores principales: | Standaert, B., Dort, T., Linden, J., Madan, A., Bart, S., Chu, L., Hayney, M. S., Kosinski, M., Kroll, R., Malak, J., Meier, G., Segall, N., Schuind, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501410/ https://www.ncbi.nlm.nih.gov/pubmed/31060567 http://dx.doi.org/10.1186/s12955-019-1147-4 |
Ejemplares similares
-
Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults
por: Madan, Anuradha, et al.
Publicado: (2016) -
Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial
por: Schuind, Anne, et al.
Publicado: (2015) -
Effectiveness of monovalent rotavirus vaccine in the Philippines
por: Lopez, Anna Lena, et al.
Publicado: (2018) -
Microtitration of Rubella Virus in Monovalent Vaccinal Products
por: Esna-Ashari, F, et al.
Publicado: (2011) -
Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant
por: Chen, Wilbur H., et al.
Publicado: (2014)